Succeeder(SH:688338) Xin Lang Cai Jing·2026-02-06 05:39Group 1 - The core viewpoint of the news is that Saikexide's stock has experienced a significant increase, with a 5.1% rise on February 6, reaching a price of 34.59 yuan per share, and a total market capitalization of 3.671 billion yuan [1] - Saikexide has seen a cumulative increase of 15.55% over the past three days, indicating strong market performance [1] - The company specializes in the research, production, and sales of diagnostic instruments, reagents, and consumables in the field of thrombosis and hemostasis, with its main revenue sources being reagents (53.71%), instruments (25.40%), and consumables (20.58%) [1] Group 2 - Qianhai Kaiyuan Fund holds a significant position in Saikexide, with its Event-Driven Mixed A Fund (000423) owning 134,100 shares, accounting for 4.77% of the fund's net value, making it the third-largest holding [2] - The fund has realized a floating profit of approximately 225,300 yuan today, and a total of 594,200 yuan during the three-day increase [2] - The fund has shown a year-to-date return of 8.42% and a one-year return of 32.69%, ranking 1299 out of 8873 and 3522 out of 8123 in its category, respectively [2]